Database release details for the first release in 2021 of the Guide to PHARMACOLOGY database, version 2021.1
Database release details for the first release in 2021 of the Guide to PHARMACOLOGY database, version 2021.1
Database release details for the first release in 2021 of the Guide to PHARMACOLOGY database, version 2021.1
Database release details for the first release in 2021 of the Guide to PHARMACOLOGY database, version 2021.1
We are pleased to announce the latest release of the Guide to PHARMACOLOGY database, version 2020.5. This is the last planned release for 2020. The 2020.5 release contains: 1,567 human targets with curated quantitative ligand interactions. 10,659 ligands, 7,884 of…
The new respiratory coronavirus from Wuhan in China is causing intense research activity in the world. Viruses are evidently associated with respiratory infections ranging in severity from the common cold to pneumonia and death
At the beginning of October 2018 we held a meeting in Edinburgh focussed on the launch of the IUPHAR Guide to IMMUNOPHARMACOLOGY. Invited speakers contributed to productive discussions on the varying challenges and opportunities in immunopharmacology research. Immunopharmacology: The New…
The 4th alpha-release (v4.0) of the Guide to IMMUNOPHARMACOLOGY was released on 23rd March 2017. This blog post summarises some of the main features of the release and other developments as we moved toward our first public, beta-release in Spring…
The latest ‘state of the field’ IUPHAR reviews are out in the British Journal of Pharmacology: Karnik SS, Khuraijam D, Tirupula K, Unal H. (2017) Significance of Ang(1-7) coupling with MAS1 and other GPCRs to the Renin-Angiotensin System: IUPHAR Review…
We are very pleased to announce a new initiative (from 1st Nov 2015) to establish “The Guide to Immunopharmacology: Integration of targets, diseases and therapies into an expert-driven database”. This project will be supported by a 3-year grant awarded to…